GlobeImmune, Inc. is a biopharmaceutical company. It engages in the development of therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform. The company was founded by Donald Bellgrau, Richard C. Duke, and Alex Franzusoff on February 10, 1995 and is headquartered in Louisville, CO.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for GlobeImmune Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. GlobeImmune Inc 52 week high is $0.0003 as of June 06, 2024.
What is the 52-week low for GlobeImmune Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. GlobeImmune Inc 52 week low is $0.00 as of June 06, 2024.
What is the 50-day moving average of GlobeImmune Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. GlobeImmune Inc 50-day moving average is $0.00.